老年心房颤动相关性缺血性脑卒中预防研究进展
被引量:4
摘要
心房颤动(简称房颤)是临床最常见的心律失常.老年人中发病率相当高。过去十几年里对房颤的研究,为了尽量减少房颤引起的危害性.减轻其对社会、家庭造成的沉重负担。主要针对房颤的复律、控制心室律、抗血栓预防等方面进行研究。然而对每位患者而言,需根据具体情况选择不同的治疗方案。在老年房颤患者中.抗血栓形成治疗尤其显得重要。
出处
《江西医药》
CAS
2008年第7期748-751,共4页
Jiangxi Medical Journal
参考文献14
-
1杜昕,马长生.心房颤动的再认识(一)[J].中国心血管病研究,2005,3(10):725-727. 被引量:33
-
2许俊堂.非瓣膜病性房颤的抗栓疗法[J].中国医刊,2006,41(9):44-47. 被引量:2
-
3Daniel E,Singer Gregory W,Albers,James,E,et al.Antithrombotic Therapy in Atrial Fibrillation:The seventh Accp conference on Antithrombotic and Thrombolytic Therapy. Chest ,2004,126:429s.
-
4胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
-
5Fuster V, RydenLE. Asubger RW, et al.ACC/AHA/ESC guidelines for thf management of patients with atrial fibrillation. European Heart J, 2001,22:1852.
-
6Hohnloser SH,Pajitnev D,pague J,et al.ACTINE W Investigators,Incidence of stroke in paroxysmal versus sustained atrial fibrirllation in patients taking oral anticoag ulation or combined antiplatelet therapy: an ACTIVE W substudy.J Am coil cardiol, 2007,27;50(22):2156.
-
7Yamaguchi T.Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation. Stroke,2000,31:817.
-
8马长生,何华.心房颤动的华法林抗凝及相关问题.胡大一,马长生,主编.心脏病学实践2007-新进展与临床案例.北京:人民卫生出版社.2007.459.
-
9Ford GA,Choy AM,Deedwania P,et al.SPORTIF Ⅲ ,V Investigators. Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF Ⅲ and V Trials. Stroke,2007,38(11):2965.
-
10Halperin JL,the executive steering commttee,on behalf of the SPORTIFIII and V study investigators.Ximelagatran compared with warfarin for prevention of thromboembolism in paients with nonvalvular atrial fibrillation;rationale,objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIFIII and V ). Am Heart J, 2003,146(3):431.
二级参考文献11
-
1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1398
-
2张学义,张薇,郑兆通,钟明,黎莉,张运.非瓣膜性心房颤动并发缺血性脑卒中的防治[J].中华急诊医学杂志,2004,13(9):592-594. 被引量:21
-
3Arboix A,Lluis GE,Massons JB,et al.Atrial fibrillation and stroke:clinical presentation of cardioembolic versus atherothrombotic infarction.Int J Cardiol,2000,73:33-42.
-
4Petersen P,Boysen G,Godtfredsen J,et al.Placebo controlled,randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation.Lancet,1989,338:175-179.
-
5European Atrial Fibrillation Trial Study Group.Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.Lancet,1993,342:1255-1262.
-
6Stroke Prevention in Atrial Fibrillation Investigators.Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation:stroke prevention in atrial fibrillation Ⅱstudy.Lancet,1994,343:687-691.
-
7Gullov AL,Koefoed BG,Petersen P,et al.Fixed mini-dose warfarin and aspirin alone and in combination versus adjusted-dose warfarin for stroke prevention in atrial fibrillation:Second Copenhagen Atrial Fibrillation,Aspirin,and Anticoagulation Study.Arch Intern Med,1998,158:1513-1521.
-
8Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.The European Atrial Fibrillation Trial Study Group.N Engl J Med,1995,333:5-10.
-
9戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量:380
-
10胡大一,孙艺红,周自强,李奎宝,倪永斌,杨光,孙淑红,李蕾.中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究[J].中华内科杂志,2003,42(3):157-161. 被引量:360
共引文献194
-
1雷礼姣,吴君,冯立娅,彭素文,胡梦颖.门诊药师窗口发放华法林钠对患者用药交待内容的探讨[J].医学信息,2017,30(2):140-141.
-
2滕海英,曹丽霞,贾百全,是明启.非瓣膜病心房颤动致脑栓塞100例临床分析[J].医学信息(医学与计算机应用),2014,0(1):370-370.
-
3王瑶,张劲松,姜丽丽,万芬,陈旭锋,蒋雷.急性缺血性脑卒中合并上肢动脉栓塞三例救治分析[J].中华危重症医学杂志(电子版),2022,15(5):399-404.
-
4舒燕,陈晓平.血管紧张素受体拮抗剂对心房纤颤的影响[J].华西医学,2008,23(5):1201-1202. 被引量:2
-
5马希,孙飞,李莉娟,陶四明.心房纤颤56例口服华法林的护理[J].中国误诊学杂志,2009,9(5):1174-1175.
-
6中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中国医学前沿杂志(电子版),2011,3(3):84-93. 被引量:84
-
7袁大军.房颤抗凝治疗问题的探讨[J].医学与哲学(B),2006,27(6):38-39.
-
8黄从新,马长生,杨延宗,黄德嘉,张澍,江洪,杨新春,吴书林,马坚,刘少稳,李莉,曹克将,王方正,陈新.心房颤动:目前的认识和治疗建议(二)[J].中华心律失常学杂志,2006,10(3):167-197. 被引量:269
-
9孙艺红,胡大一,张鹤萍,姜立清.低危非瓣膜病心房颤动患者抗栓疗效分析[J].中国医药导刊,2006,8(4):240-242. 被引量:4
-
10达娃次仁,赵锋.血管紧张素转换酶抑制剂及血管紧张素受体阻断剂对房颤的预防作用[J].中国心血管病研究,2006,4(11):857-859. 被引量:5
同被引文献42
-
1岳晓军,胡志兵,李婉媚,戴建武,江朝强.老年人慢性心房颤动病因及与脑卒中的关系[J].中西医结合心脑血管病杂志,2005,3(9):813-814. 被引量:5
-
2孙艺红.心房颤动与脑卒中[J].中华全科医师杂志,2006,5(1):10-11. 被引量:14
-
3Tsai CF, Thorns B, Sudlow CL. Epidemiology of stroke and its sub- types in Chinese vs white populations: a systematic review[J]. Neu- rology, 2013, 81:264-272.
-
4Candelise L, Pinardi G, Morabito A. Mortality in acute stroke with atrial fibrillation. The Italian Acute Stroke Study Group[J]. Stroke, 1991, 22:169-174.
-
5Uri Elkayam, MD, Tien M.H.Ng, PharmD, et al. Renal Vasodilatory Action of Dopamine in Patients With Heart Failure: Magnitude of Effect and Site of Action[J]. Circulation, 2008, 117:200-205.
-
6Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in pa- tients with early renal dysfunction:a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Soliety (ANZICS) Clinical Trials Group[J]. Lancet, 2000, 23-30:2139-2143.
-
7Argalious M, Motta P, Khandwala F, et al. "Renal dose"dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery[J]. Crit Care Med, 2005, 33:1327-1332.
-
8Overgaard CB, Dzavik V. Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease[J]. Circula- tion, 2008, 118:1047-1056.
-
9Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence- based approach[J]. Circulation, 2006, 113: 1799-1806.
-
10Mc Cullough P. Outcomes of contrast-induced nephrohathy:experi- ence in patients undergoing cardiovascular intervention[J]. Catheter Cardiovasc Interv, 2006, 67:335-343.
引证文献4
-
1张树峰,张许梅,刘晶晶,马玉恒,闫旭,李春喜,刘晋.不同血管活性药物在缺血性脑卒中合并房颤患者神经介入手术中的应用效果比较[J].武警医学,2023,34(8):660-663.
-
2朱平华.房颤对老年缺血性脑卒中短期功能预后的影响观察[J].基层医学论坛,2014,18(17):2212-2213. 被引量:2
-
3张树峰,刘中光,李曼,李永旺,马玉恒,韩月鹏,刘帆,陈阳.去氧肾上腺素与多巴胺在缺血性脑卒中合并心房颤动患者神经介入术中的应用[J].北京医学,2016,38(1):1-4. 被引量:5
-
4夏莺,王红鸾,郭韶梅,蔡金莲,王爱平,汪俊,殷然.改良的CHA_2DS_2-VASc评分对房颤患者左心房血栓的诊断价值[J].江西医药,2016,51(3):189-191. 被引量:4
二级引证文献11
-
1张树峰,张许梅,刘晶晶,马玉恒,闫旭,李春喜,刘晋.不同血管活性药物在缺血性脑卒中合并房颤患者神经介入手术中的应用效果比较[J].武警医学,2023,34(8):660-663.
-
2敬宏宇,甘晨阳,李坤.左房内径与心房颤动的相关性分析[J].临床心电学杂志,2020,29(6):436-438. 被引量:5
-
3黄顺贵,刘梅,王彬,钟晓闵,龙秀英,宋春江.神经介入疗法治疗脑血管疾病的临床效果及安全性[J].临床合理用药杂志,2018,11(33):3-4. 被引量:5
-
4梁旺颜,严文,杨晓云,左杏梅,麦光怀.适时心理干预对脑卒中康复的影响[J].按摩与康复医学,2017,8(4):56-57. 被引量:2
-
5池钢,周琪,张析哲.右美托咪定复合依托咪酯对脑卒中介入治疗的麻醉效果[J].中国继续医学教育,2018,10(14):73-74. 被引量:12
-
6张缤迎,陈静,曾茜茜,江小玲,宋胜伟.D-二聚体检测在血栓性疾病诊断中的意义[J].江西医药,2018,53(7):766-767. 被引量:3
-
7肖金平,付景秋,李小雷,陈俊.心房颤动病人射频消融前后miRNA-328、miRNA-223表达与预后的关系[J].中西医结合心脑血管病杂志,2020,18(21):3636-3639. 被引量:3
-
8张娟.血栓性疾病患者进行血浆D-二聚体检测的临床意义探讨[J].中国实用医药,2021,16(13):43-45. 被引量:3
-
9刘婷婷,刘海兰,邹文,方译,郑春华,宋嫣.经食道超声心动图在房颤患者左心耳封堵术中的应用价值[J].江西医药,2022,57(8):847-849. 被引量:3
-
10李从磊.神经血管介入手术麻醉复苏的临床效果分析[J].世界最新医学信息文摘,2017,17(91):163-163.
-
1李继华,张忠群.华法林联合辛伐他汀防治老年心房颤动脑卒中疗效及安全性评价[J].临床和实验医学杂志,2008,7(8):92-93. 被引量:3
-
2徐谦,栗亚新.老年房颤患者发生脑栓塞的分析[J].中国现代医生,2009,47(14):154-155. 被引量:1
-
3章琳慧,苏严琳.动机性访谈对促进非瓣膜性房颤患者服用华法令的依从性的调查[J].中西医结合护理(中英文),2016,2(3):38-40. 被引量:2
-
4陈尧飞.华法林在老年心房颤动抗凝治疗中的疗效分析[J].中国医药指南,2014,12(1):107-108. 被引量:2
-
5丁同斌,刘士超,简立国.老年心房颤动并发脑梗死127例分析及抗凝治疗[J].中国实用神经疾病杂志,2016,19(13):75-76. 被引量:2
-
6张晓雪,赵洪礼,姚成芳.中药对脑血管的保护作用及其防治脑血栓形成的研究进展[J].中国民康医学,2010,22(9):1146-1149. 被引量:12
-
7袁志敏(摘译),刘运德(校).心房颤动患者伴短暂脑缺血发作相关研究[J].心血管病学进展,2005,26(5):568-568.
-
8王丽英,刘文宏,王效敏.老年人心房颤动致脑栓塞40例临床特点分析[J].中国综合临床,2007,23(3):206-207. 被引量:3
-
9李莉,李全利.87例房颤患者复律前后脑电图分析[J].临床神经电生理学杂志,2001,10(3):177-177.
-
10王涌涛,张悦.华法令对老年房颤患者脑卒中发病率的影响[J].中国实用医药,2008,3(22):93-94. 被引量:4